CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral Biomedical Holdings, Inc. (OTCQB:ENUM), today announced that Arthur H. Tinkelenberg, Ph.D., President and Chief Executive Officer of Enumeral, will participate in a panel discussion, titled “Continued Opportunities in Immuno-Oncology; Exploring Next-Generation Checkpoint Inhibition,” at the Cantor Fitzgerald Inaugural Healthcare Conference, to be held at Le Parker Meridien Hotel in New York City on Wednesday, July 8, 2015 at 11:15 AM ET.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
